Lunai Bioworks
LNAI
29 hedge funds and large institutions have $5.31M invested in Lunai Bioworks in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
61% more funds holding
Funds holding: 18 → 29 (+11)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
19% less capital invested
Capital invested by funds: $6.6M → $5.31M (-$1.28M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.03M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$333K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$326K |
| 4 |
State Street
Boston,
Massachusetts
|
+$198K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$180K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$590K |
| 2 |
WIA
World Investment Advisors
Santa Barbara,
California
|
-$404K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$227K |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$129K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$93.6K |
LNAI Hedge Fund Activity: Q2 2019 in Review
29 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q2 2019, worth a combined $5.31M — down 19% from $6.6M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new LNAI positions and 5 closed out — a net gain of 11 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was BlackRock, adding an estimated $1.03M. The largest seller was Goldman Sachs, cutting an estimated $590K.
- 29 institutional investors held Lunai Bioworks (LNAI) as of Q2 2019, up from 18 in Q1 2019.
- Funds reported $5.31M of Lunai Bioworks stock for Q2 2019, down 19% quarter-over-quarter.
- 16 funds opened new Lunai Bioworks positions in Q2 2019 and 5 closed out, a net change of +11 holders.
- The largest Lunai Bioworks buyer in Q2 2019 was BlackRock, an estimated $1.03M added.
- The largest Lunai Bioworks seller in Q2 2019 was Goldman Sachs, an estimated $590K sold.
Based on aggregated 13F filings for Q2 2019.